Navigation Links
Encorium Announces NASDAQ Panel Decision to Delist Common Stock; Announces Changes to its Board of Directors
Date:10/22/2010

and uncertainties, and actual results could differ materially from those discussed. Factors that could cause or contribute to such differences include, but are not limited to: (i) market makers not continuing to make a market in the Company's common stock, (ii) the ability of the Company's common stock to be quoted on the OTCQB, (iii) the Company's ability to continue as a going concern, (iv) the Company's ability to service its principal and interest obligations on its outstanding debt or otherwise renegotiate or refinance such outstanding debt, which renegotiation may not be successful and refinancing may not be available on acceptable terms, if at all, which may trigger defaults under its other debt agreements, create liquidity issues, potentially force the Company to file for protection from its creditors under Chapter 11 of the U.S. Bankruptcy Code and prevent the Company from continuing as a going concern; (iv) the risk that we may not have sufficient funds to operate our business; (v) our success in attracting new business and retaining existing clients and projects; (vi) the size, duration and timing of clinical trials we are currently managing may change unexpectedly; (vii) the termination, delay or cancellation of clinical trials we are currently managing could cause revenues and cash-on-hand to decline unexpectedly; (viii) the timing difference between our receipt of contract milestone or scheduled payments and our incurring costs to manage these trials; (ix) outsourcing trends in the pharmaceutical, biotechnology and medical device industries; (x) the ability to maintain profit margins in a competitive marketplace; (xi) our ability to attract and retain qualified personnel; (xii) the sensitivity of our business to general economic conditions; (xiii) other economic, competitive, governmental and technological factors affecting our operations, markets, products, services and prices; (xiv) announced awards received from existing and potential
'/>"/>
SOURCE Encorium Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors
2. Encorium Reports Third Quarter 2008 Financial Results
3. Encorium Announces Receipt of Letter from Nasdaq Regarding its Third Quarter 2008 Form 10-Q Filing
4. Encorium Group Signs $3.1 Million of New Business Contracts Including an Extension of a Current U.S. Oncology Clinical Trial with a Major Pharmaceutical Company
5. Encorium Group Signs Approximately $2.0 Million of New Business Contracts
6. Encorium Named as Finalist for the Second Annual Vaccine Industry Excellence Award
7. Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team
8. Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business
9. Encorium Group Completes Sale of its U.S. Business to Pierrel Research USA; Announces Management Changes
10. Encorium Reports Second Quarter 2009 Financial Results
11. Encorium Announces Receipt of Letters from Nasdaq Regarding its Second Quarter 2009 Form 10-Q Filing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Carahsoft and CDS Federal Services have scheduled a ... EST (11am PST), “Natural Language Processing: Converting Raw Data ... can turn raw, heterogeneous data into actionable knowledge to ... webinar will last approximately one hour. , Synopsis: Big ...
(Date:1/14/2014)... 14, 2014 As pet owners drew up their lists of ... wrote: "Take better care of my furry companion." Nowadays there are ... top-brand carrying cases to take the little canine or feline darlings ... compelled to buy some pricey toys at the pet store. But ...
(Date:1/14/2014)... SAN DIEGO and BETHESDA, Md. ... they are joining together with two institutes from the ... more reliable tools for bringing safer, more effective treatments ... with the National Center for Advancing Translational Sciences (NCATS) ...
(Date:1/14/2014)... Jan. 14, 2014  RXi Pharmaceuticals Corporation (OTCQX: RXII), ... commercializing innovative therapies addressing major unmet medical needs ... the Notice of Allowance from the United States ... RNAi compounds (sd-rxRNA®), for the treatment of fibrosis. ...
Breaking Biology Technology:Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3
... Services Inc., leads a videocast discussion with top executives on ... to Asia. , ... (PRWEB) November ... Atlanta, Georgia, Jim Miller, president of PharmSource Information Services Inc., ...
... Arpida,announced today that it is refocusing all projects and ... is to be seen as a,consequence of the negative recommendation ... 20 November 2008 regarding the,approval of Iclaprim in the U.S. ... of the FDA advisory board,s recommendation the Arpida,board intends to ...
... sailing a spacecraft by the optical force of the sun,s light. ... the oversized sails that have been tried. Now a team led ... Science has shown that the force of light indeed can ... to nano-proportions. , Their work opens the door to a ...
Cached Biology Technology:PharmSource President Moderates Videocast on Outsourcing to Asia at AAPS 2Arpida to Restructure and Focus on Key Projects 2'The photon force is with us': Harnessing light to drive nanomachines 2
(Date:4/24/2014)... International Glossina Genome Initiative (IGGI) has produced the first ... morsitans . The blood-sucking insect is the sole transmitter ... sub-Saharan Africa. The vast store of genetic data will ... and provide insights into the tsetse fly,s unique biology. ... insect world: it feeds exclusively on the blood of ...
(Date:4/24/2014)... 2014D-ribose is a commercially important sugar used as ... starting compound for synthesizing riboflavin and several antiviral ... to increase the bacteria,s ability to produce D-ribose ... industrial-scale production of this valuable chemical, as described ... a peer-reviewed journal from Mary Ann Liebert, Inc., ...
(Date:4/24/2014)... Researchers at Ludwig-Maximilians-Universitaet (LMU) in Munich have identified ... system to discriminate between viral and endogenous RNAs ... they take control of cellular metabolism and hijack ... This process is dependent on viral RNA molecules ... of RNA viruses) and/or newly synthesized in the ...
Breaking Biology News(10 mins):Genetic code of the deadly tsetse fly unraveled 2Viral infections: Identifying the tell-tale patterns 2Viral infections: Identifying the tell-tale patterns 3
... from Boston College have developed a new class of ... that reveals the telltale signs of cellular death, particularly ... in the current electronic edition of the Journal ... by Assistant Professor of Chemistry Jianmin Gao successfully grafted ...
... fuel economy is on everyone,s minds these days. The ... is no exception. For several years, the transit authority, ... fleet in an effort to curb the transportation system,s fuels costs. ... hybrids is the question the University of Houston has been asked ...
... of California, Berkeley, are offering hope to the 10 percent ... often high-pitched ringing or buzzing in the ears that can ... Their new findings, published online last week in the journal ... several new approaches to treatment, including retraining the brain, and ...
Cached Biology News:Small molecule receptor detects lipid's telltale sign of cell death 2University of Houston to test local buses for fuel efficiency 2Tinnitus discovery could lead to new ways to stop the ringing 2Tinnitus discovery could lead to new ways to stop the ringing 3
... The Synaptic Vesicles Isolation Kit ... preparing an enriched synaptic vesicle fraction. ... hypo-osmotic lysis of the synaptosomes, and ... density gradient. The kit also contains ...
... The Ultra Silica Bead Kit has been designed ... gels and solutions. Features Ultra ... minutes Uniform silica beads are easy to resuspend ... DNA Highly pure DNA (suitable for PCR) ...
... simple and efficient method for purification of DNA ... DNA fragments selectively absorbed in the spin column ... at room temperature for PCR product with equal ... of DNA can be purified with a single ...
When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human HLA-DR TAC is designed to deplete human HLA-DR from samples to isolate resting CD4+ or CD8+ T cells....
Biology Products: